➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: September 24, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR OLOPATADINE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Olopatadine Hydrochloride

Subscribe to access the full database, or Free Forever Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00331500 ↗	Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis	Completed	Alcon Research	Phase 3	2006-08-01	The purpose of this study is to demonstrate that Olopatadine 0.2% is superior to vehicle in the treatment of the signs and symptoms associated with allergic conjunctivitis or rhinoconjunctivitis.
NCT00389025 ↗	Mast-Cell Stabilizing Effects of Olopatadine	Completed	Alcon Research	Phase 4	2006-10-01	To assess the effects of olopatadine of the release of mast cell histamine
NCT00489398 ↗	Comparison of CL Wear Between Two Allergy Drops	Withdrawn	Merck Sharp & Dohme Corp.	Phase 4	2007-07-01	Comparison of two allergy drops for enhancing comfort and performance of contact lens wear
NCT00489398 ↗	Comparison of CL Wear Between Two Allergy Drops	Withdrawn	Hom, Milton M., OD, FAAO	Phase 4	2007-07-01	Comparison of two allergy drops for enhancing comfort and performance of contact lens wear
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Olopatadine Hydrochloride

Condition Name

Chart
Table

Condition Name for Olopatadine Hydrochloride
Intervention	Trials
Allergic Conjunctivitis	19
Seasonal Allergic Rhinitis	5
Conjunctivitis, Allergic	5
Allergic Rhinitis	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Olopatadine Hydrochloride
Intervention	Trials
Conjunctivitis, Allergic	28
Conjunctivitis	27
Rhinitis	14
Rhinitis, Allergic	13
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Olopatadine Hydrochloride

Trials by Country

Map
Table

Trials by Country for Olopatadine Hydrochloride
Location	Trials
United States	57
Canada	4
Japan	4
India	2
France	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Olopatadine Hydrochloride
Location	Trials
Texas	9
Massachusetts	4
Tennessee	3
Wisconsin	3
Illinois	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Olopatadine Hydrochloride

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Olopatadine Hydrochloride
Clinical Trial Phase	Trials
Phase 4	20
Phase 3	13
Phase 2	5
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Olopatadine Hydrochloride
Clinical Trial Phase	Trials
Completed	33
Recruiting	3
Withdrawn	2
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Olopatadine Hydrochloride

Sponsor Name

Chart
Table

Sponsor Name for Olopatadine Hydrochloride
Sponsor	Trials
Alcon Research	20
Allergan	3
Merck Sharp & Dohme Corp.	2
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Olopatadine Hydrochloride
Sponsor	Trials
Industry	36
Other	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys

Colorcon

Johnson and Johnson

Medtronic

Mallinckrodt

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.